mojo I do not have enough info to answer that question. Changing material would only improve strength and flexibility of the components being changed. Bernard mentioned MIM and certain types of MIM stainless materials not being available which is true. The thing to keep in mind is that MIM raw material is not the same as wrought steel at a microscopic level and does in no way have the same properties....eg a 400 series MIM part would not have the same properties as a the same 400 series wrought steel. I'm not going into the details here. It depends on what they are trying to accomplish......last call at the Q report they stated redesign to the Blue lockout mechanism. Im just speculating here.
wow If they read this post i made in may 2012 they would have avoided the MIM part they are now going to machine....referenced in the call
Gee I hope they are getting advice from MBs that would be scary......no actually the "group think" is underestimated......unfortunate that one has to sift through the poo to get decent posts to read. Isnt there an algorithm out there that monitors the entire web to make predictions about pending major events.....its like technical analysis.....it works because there is something fundamental behind the movements that may be unknown.....its essentially watching what other people know.....inside info trading is real and very difficult to prove....for example I would suspect guys that work at cardica would tell their buddies yo buy this now its gunna pop soon when announcements are made ....we just finished engineering tests and we got it.......then the stock starts to move a little..and the trend changes a little...then the techies detect it with their programs and they start watching and jump in and then finally when news is announced its late stage info. Likewise if enough people chime in on this blog with relevant info they could sift through and pick up bits of good info....but there aren't many value posts.
Procedures to be applied to other disease states.....such as arthritis...forgive my ignorance as I am new to this companies IP and have been trying to study it to gain a general understanding. It appears that in part there is a slow controlled delivery mechanism for stem cells at localized damage site. As I understand it there is a bio-absorb polymer that releases stem cells as it degrades.....is this correct? As for scaffold is this a term used for the structure of the implant? Can this technology be applied to arthritis with a redesigned scaffold that releases stem cells to an area of arthritis......again please pardon my ignorance here just new to this co and may want to buy on dips as we are currently seeing.
Ya you can see the woman has a difficult time getting her hands around it....now imagine the device is loaded with tissue and she needs to fire through 4 squeezes it will be difficult for her to handle ....OK this posts sets up some bad replies
It probably would....a clean bum is a happy bum and no hemorrhoids ....Qlav is a preventive measure.....maybe Cardica could invent such a wonderful device.
unlike Pharm this is a mechanical device and is correctable. They already have earlier gen devices that work although with lower range....its not like the design is a total failure if they don't cover all thicknesses...they allegedly have a viable portfolio planned based on a new staple design....even if it were all the same size as the current market offerings it would still offer some significant advantages....not sure why this is continuously overlooked...The mechanical issues are always solvable and this one in my opinion and experience is minor. The small size of the device may require some unique materials and design features to strengthen or stiffen its components......as for device lock out to prevent firing on tissue too thick its better to have a passive lockout then an active one...that is do not allow the device to engage for fire rather than blocking a fire......as blocking a fire can have a fail mode of the blocking mechanism damage and subsequent firing.....
The Maya no longer exist......probable scenario for Cardica?
There are 2 ways to be fooled....believing what is not true and not believing what is true. also known as alpha and beta errors. And then their is the lazy I don't care scenario which is predominant these days.
The Maya would have faired better if they didn't believe a lie.......is this really a good analogy for Cardica?
So is Cardica management working a false flag here or are they just that incompetent? I wouldn’t be surprised if they were working with an entity to pressure the stock downward in a collusion. Of course this is my cynical opinion only. Maybe Knodel was fired because he didn’t want to go along with it….either way when the cards are all laid out questions will be asked.
FROM 13D Feb 17, 2015
Prescott Capital is the beneficial owner of 3,193,781 shares of Common Stock and Mr. Phil Frohlich is the beneficial owner of 3,193,781 shares of Common Stock.
(b) Prescott Capital and Mr. Phil Frohlich are the beneficial owners of 3.6% of the outstanding shares of Common Stock. This percentage is determined by dividing 3,193,781 by 88,955,216, the number of shares of Common Stock issued and outstanding as of November 6, 2014, as reported in the Issuer’s 10-Q filed on November 12, 2014.
(c) Prescott Capital, as the general partner of the Small Cap Funds, the general partners of Prescott Master Fund, may direct the Small Cap Funds to direct the vote and disposition of the 3,193,781 shares of Common Stock held by PrescottMaster Fund. As the principal of Prescott Capital, Mr. Phil Frohlich may direct the vote and disposition of the 3,193,781 shares of Common Stock held by Prescott Master Fund.
mojo i agree....I understand Hausen's desire to have a superb product and that should continue to be the ongoing goal even after the launch....but i would think that a saleable product with some unfished desires (not quality or safety related) is better than none.....to attain some cash flow and keep improving.....heck even an exact copy of whats currently on the market now would have value to some Med companies like applied.....regardless of all the differentiation Hausen is working on....What i like is that Hausen has a good connection to voice of customer.....its amazing to me how poorly voice of customer is sometimes conducted. In non applied situations it so strange most customers are really afraid to be honest in fear of insulting even when the producer of product or service is not the one asking rather 3rd party. Its what goes on in the OR if you were a fly on the wall watching everywhere all the time...hopefuly there are no flies on the walls BTW. If VOC lead Hausen to develop the microcutter why didnt the big 2 or some other device company have it in the works if their VOCs were giving the same feedback
I think Knodel is a smart guy and lead the way for their designs however if they are shifting to a mode of just developing the IP that has been established they may only need Knodel as a consult. Its difficult to speculate on not knowing why they let him go....hopefully it was not for reasons of integrity but rather just cutting cost. It does appear that Cardica does have other innovation guys.....and i say that because engineer does not always equal innovative and visa versa....